Oxycodone Market Analysis

  • Report ID: 3794
  • Published Date: May 08, 2025
  • Report Format: PDF, PPT

Oxycodone Segmentation

Route of Administration (Oral, Intravenous)

The oral segment is estimated to gain the largest market share of about 45% in the year 2037. The growth of the segment can be accredited to the oxycodone retains half of its analgesic properties when taken orally, hence the safer effects of oxycodone when taken orally. Across the world, it has been noted that aged people are more prone to cancer and for them oral route of administration is much easier than intravenous or other methods. Overall cancer incidence increases steadily with age, from less than 25 cases per 100,000 under 20 years to more than 1000 cases per 100,000 people for aged 60 years and over.

End-user (Hospitals, Oncological Centers, Drug Stores)

The hospital segment is expected to garner a significant share of around 30% in the year 2037. The growth of the segment can be accredited to the large number of patients requiring treatment for cancer conditions. The hospitals are also growing rapidly in number, which is estimated to positively influence the segmental growth. For instance, by the year 2022 there was noted to be approximately 6,100 hospitals in the United States. Hospitals provide a wide range of medical care. Physicians, called hospital doctors, typically specialize in internal medicine, pediatrics, or general practice. They have the knowledge to solve common problems and the resources to solve more complex medical problems. Hospitals may also offer specialized care, such as neurology, obstetrics and gynecology, and oncology. By definition of a hospital, a county hospital is typically a primary medical facility in a region with numerous intensive care and mobile beds for patients requiring long-term care.

Our in-depth analysis of the global market includes the following segments:

     By End User

  • Hospital
  • Oncology Centers
  • Drug Stores
  • Others

 

   

     By Route of Administration

  • Oral
  • Intravenous
  • Others

     By Application

  • Analgesic
  • Sedative
  • Others

 

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

Oxycodone Market in 2025 is evaluated at USD 11.01 billion.

The global market size was worth around USD 10.39 billion in 2024 and is set to register a CAGR of more than 7.4%, exceeding USD 26.28 billion revenue by 2037.

Asia Pacific is on pace to accumulate USD 9.2 billion by 2037, owing to growing aged population and increasing cancer rates, requiring oxycodone for treatment.

The major players in the market include Nektar Therapeutics, Thermo Fisher Scientific Inc., Boehringer Ingelheim GmbH, Bayer AG, Abbott Laboratories, Merck & Co., Inc., Esteve Pharmaceuticals, S.A., Validus Pharmaceuticals LLC, Teva Pharmaceutical Industries Ltd., Siemens Healthcare GmbH.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos